{"id":33198,"date":"2024-07-03T12:16:24","date_gmt":"2024-07-03T12:16:24","guid":{"rendered":"https:\/\/ibima.eu\/tratamiento-de-pacientes-dislipemicos-con-alto-riesgo-y-muy-alto-riesgo-para-la-prevencion-de-eventos-cardiovasculares-en-europa-estudio-multinacional-observacional-estudio-santorini-dse-hcl-01-19\/"},"modified":"2024-07-03T12:16:24","modified_gmt":"2024-07-03T12:16:24","slug":"tratamiento-de-pacientes-dislipemicos-con-alto-riesgo-y-muy-alto-riesgo-para-la-prevencion-de-eventos-cardiovasculares-en-europa-estudio-multinacional-observacional-estudio-santorini-dse-hcl-01-19","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/tratamiento-de-pacientes-dislipemicos-con-alto-riesgo-y-muy-alto-riesgo-para-la-prevencion-de-eventos-cardiovasculares-en-europa-estudio-multinacional-observacional-estudio-santorini-dse-hcl-01-19\/","title":{"rendered":"Tratamiento de pacientes dislip\u00e9micos con alto riesgo y muy alto riesgo para la prevenci\u00f3n de eventos cardiovasculares en Europa – Estudio Multinacional Observacional. Estudio SANTORINI (DSE-HCL-01-19)"},"content":{"rendered":"
PEDRO VALDIVIELSO FELICES – ESTUDIO POSAUTORIZACION COMERCIAL – DAIICHI SANKYO EUROPE GMBH<\/p>","protected":false},"excerpt":{"rendered":"
PEDRO VALDIVIELSO FELICES – ESTUDIO POSAUTORIZACION COMERCIAL – DAIICHI SANKYO EUROPE GMBH<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2263,2269],"tags":[],"acf":[],"yoast_head":"\n